Optimization of voriconazole dosage regimen to improve the efficacy in patients with invasive fungal disease by pharmacokinetic/pharmacodynamic analysis

Pharmacokinetic and Pharmacodynamic Properties of Oral Voriconazole in Patients with Invasive Fungal Infections

(2015) Taotao Wang et al.   PHARMACOTHERAPY

Efficacy and safety of voriconazole and CYP2C19 polymorphism for optimised dosage regimens in patients with invasive fungal infections

(2014) Taotao Wang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing

(2014) M. J. Dolton et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Utilization and Comparative Effectiveness of Caspofungin and Voriconazole Early after Market Approval in the U.S

(2014) Sibel Ascioglu et al.   PLoS One

Identification of factors influencing the pharmacokinetics of voriconazole and the optimization of dosage regimens based on Monte Carlo simulation in patients with invasive fungal infections

(2013) T. Wang et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring

(2012) Michael J. Dolton et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial

(2012) Wan Beom Park et al.   CLINICAL INFECTIOUS DISEASES

Challenging Recommended Oral and Intravenous Voriconazole Doses for Improved Efficacy and Safety: Population Pharmacokinetics–Based Analysis of Adult Patients With Invasive Fungal Infections

(2012) Andres Pascual et al.   CLINICAL INFECTIOUS DISEASES

Population Pharmacokinetics of Voriconazole in Adults

(2011) William W. Hope   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Observational Study of the Clinical Efficacy of Voriconazole and Its Relationship to Plasma Concentrations in Patients

(2011) Peter F. Troke et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fusarium verticillioides fungemia in a liver transplantation patient: successful treatment with voriconazole

(2011) Stefania Cocchi et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Vancomycin Dosage Optimization in Patients with Malignant Haematological Disease by Pharmacokinetic/Pharmacodynamic Analysis

(2009) Maria del Mar Fernández de Gatta et al.   CLINICAL PHARMACOKINETICS

Correlation between voriconazole trough plasma concentration and hepatotoxicity in patients with different CYP2C19 genotypes

(2009) Kazuaki Matsumoto et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders

(2009) Koki Ueda et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

(2008) Brahm H. Segal et al.   CLINICAL INFECTIOUS DISEASES

Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes

(2007) A. Pascual et al.   CLINICAL INFECTIOUS DISEASES